Pavmed Inc (PAVM) Stock Price, Quote & News

Company Profile

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precance...

Industry: Medical Devices

Sector: Healthcare

Phone: (917) 813-1828

Website: www.pavmed.com

Address:

360 Madison Avenue, 25th Floor, New York, United States

LPlates Jun. 27 at 2:54 PM

$LUCD why do you say that MolDx has dropped the ball? Why would they do that? Is it not far more LIKELY that Lishan and Dennis misled you so that they could each collect their $60K per month which puts them in the top 1%. That is Lishan and Dennis's motivation and its a very powerful one. Where are the insider purchases that shows confidence and belief? Where do they forgo salary and take it in stock instead? What is MolDx's motivation? Is it as powerful as Lishan and Dennis's desire to remain in the top 1%, particulary after their UTTER FAILURES (all 5 product launches have FAILED) means they are unemployable. You wouldnt hire them to run a lemonade stand based on their track record with $LUCD And $PAVM. So who is to blame for over promising and under delivering? People will bail hard this afternoon as Monday it could be sub $1 so a lot of retail wont want to hold over the weekend. What world will Lishan use instead of "IMMINENT" i wonder? Soon? Around the corner?

1 · Reply

DrKyle Jun. 27 at 2:44 PM

$LUCD $PAVM

1 · Reply

Carter113 Jun. 26 at 3:18 PM

$LUCD $PAVM https://www.usatoday.com/story/sponsor-story/hoag-fph/2025/06/25/we-can-eradicate-esophageal-cancer-one-california-health-systems-quest-to-end-a-deadly-disease/84152418007/

2 · Reply

BigJuicy Jun. 25 at 5:08 PM

$PAVM crushed

1 · Reply

dmc4321 Jun. 24 at 4:31 PM

The $PAVM 8K was interesting. Highlights about VERIS's $2.5M raise IMO. The BIG one is no more raises till end of 2026 After the Offering, the Company owns 75.3% of the Veris Common Stock on a fully-diluted basis. The Subscription Agreement contains customary representations, warranties, covenants and indemnities of Veris and the Investors, as well as a covenant by Veris to provide the Investors with protection against subsequent equity raises by Veris at a lower valuation (solely to the extent the Investors continue to hold the shares issued in the Offering), with such protection to be effected through the issuance of additional shares of Veris Common Stock. In addition, Veris granted certain of the Investors a 100% participation right in future offerings of equity securities by Veris, subject to existing participation rights of the Company’s debt holder, and agreed not to incur any indebtedness until December 23, 2026, subject to certain exceptions.

0 · Reply

tds_ Jun. 24 at 12:04 PM

$PAVM "This financing, at an attractive valuation, reflects strong investor confidence in Veris' commercial potential and represents an important milestone for both PAVmed and Veris," said Lishan Aklog, M.D., Chairman and CEO of PAVmed and Executive Chairman of Veris Health. "Veris is now sufficiently capitalized to fund development of its implantable physiological monitor through FDA clearance and subsequent commercial launch. The monitor—designed to enhance personalized care in conjunction with the Veris Cancer Care Platform—will serve as a key commercial differentiator."

0 · Reply

tds_ Jun. 24 at 12:04 PM

$PAVM PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing Veris sold shares of its common stock at $1.40 per share, reflecting a pre-money valuation of approximately $35 million. Veris will use the proceeds to advance its implantable physiological monitor through FDA clearance, expected in 2026, and for general corporate purposes. https://ir.pavmed.com/2025-06-24-PAVmed-Subsidiary-Veris-Health-Completes-2-5-Million-Direct-Equity-Financing

0 · Reply

Thegame7000 Jun. 24 at 11:22 AM

$PAVM You Can…DO EEEIIITTTTT!

0 · Reply

Carter113 Jun. 23 at 10:37 PM

$LUCD $PAVM https://www.pharmabiz.com/NewsDetails.aspx?aid=178644&sid=2

1 · Reply

LPlates Jun. 23 at 4:04 PM

$LUCD So the "so called" Big Money, which had to rely on UNACCREDITED INVESTORS to fund $5M of a measly $15M round this Qtr? Is that showing confidence? Everybody should panic. All the X PUMPERS havent posted in over two weeks. They were all posting multiple times a week, sometimes daily for the 3 months previously. Why the sudden radio silence? Could they be dumping as volume jad halved. Come Monday this whole PUMP about a 1st half decision will be shown to be just that. Lishan and Dennis mislead ALL THE TIME. It is their de facto way of operating. Rwmember if people have followed your reccomendations they will need $LUCD to go up 10X to just break even. Thats a market cap of OVER $2BILLION. Just like your $PAVM recommendation where a $10,000 investment is TODAY worth $60. Not a typo. SIXTY dollars left out of 10 THOUSAND DOLLARS invested So maybe not PUMPING would be better?

0 · Reply

PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing

Jun 18, 2025, 12:02 PM EDT - 9 days ago

Market Cap	10.51M
Revenue (ttm)	3.00M
Net Income (ttm)	39.79M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	1,326.33%
Debt to Equity Ratio	0.00

Volume	94,177
Avg Vol	160,892
Day's Range	N/A - N/A
Shares Out	17.09M
Stochastic %K	44%
Beta	1.06
Analysts	Strong Sell
Price Target	$11.50